These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 26519197

  • 1. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
    Kartal K, Onder S, Kosemehmetoglu K, Kilickap S, Tezel YG, Kaynaroglu V.
    BMC Cancer; 2015 Oct 30; 15():824. PubMed ID: 26519197
    [Abstract] [Full Text] [Related]

  • 2. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B, Polat SB, Baser H, Ozdemir D, Kilicarslan A, Yalcin A, Ersoy R, Cakir B.
    Cytopathology; 2017 Aug 30; 28(4):259-267. PubMed ID: 27666595
    [Abstract] [Full Text] [Related]

  • 3. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
    Chia SY, Milas M, Reddy SK, Siperstein A, Skugor M, Brainard J, Gupta MK.
    J Clin Endocrinol Metab; 2007 Feb 30; 92(2):468-75. PubMed ID: 17118994
    [Abstract] [Full Text] [Related]

  • 4. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
    Rosario PW.
    Thyroid; 2014 Jul 30; 24(7):1115-20. PubMed ID: 24684285
    [Abstract] [Full Text] [Related]

  • 5. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG, Kim JH, Sung JY, Baek JH, Jung KC, Lee H, Yoo H.
    Thyroid; 2012 May 30; 22(5):468-75. PubMed ID: 22304417
    [Abstract] [Full Text] [Related]

  • 6. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
    Topaloglu O, Baser H, Cuhaci FN, Sungu N, Yalcin A, Ersoy R, Cakir B.
    Endocrine; 2016 Oct 30; 54(1):156-168. PubMed ID: 27172917
    [Abstract] [Full Text] [Related]

  • 7. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Baca SC, Wong KS, Strickland KC, Heller HT, Kim MI, Barletta JA, Cibas ES, Krane JF, Marqusee E, Angell TE.
    Cancer Cytopathol; 2017 May 30; 125(5):313-322. PubMed ID: 28152275
    [Abstract] [Full Text] [Related]

  • 8. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.
    Thyroid; 2013 Jun 30; 23(6):703-8. PubMed ID: 23544697
    [Abstract] [Full Text] [Related]

  • 9. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, Wylie D, Beaudenon-Huibregtse S.
    J Clin Endocrinol Metab; 2015 Jul 30; 100(7):2743-50. PubMed ID: 25965083
    [Abstract] [Full Text] [Related]

  • 10. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, Song DE, Shong YK, Hong SJ.
    Thyroid; 2014 Mar 30; 24(3):494-501. PubMed ID: 23947771
    [Abstract] [Full Text] [Related]

  • 11. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL, Faquin WC, Samir AE.
    AJR Am J Roentgenol; 2015 Oct 30; 205(4):861-5. PubMed ID: 26397337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, Cakir B, Guler G.
    Cytopathology; 2014 Jun 30; 25(3):185-9. PubMed ID: 24024935
    [Abstract] [Full Text] [Related]

  • 19. Subclassification of "atypia of undetermined significance" in thyroid fine-needle aspirates.
    Wu HH, Inman A, Cramer HM.
    Diagn Cytopathol; 2014 Jan 30; 42(1):23-9. PubMed ID: 24166935
    [Abstract] [Full Text] [Related]

  • 20. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance.
    Yoo WS, Choi HS, Cho SW, Moon JH, Kim KW, Park HJ, Park SY, Choi SI, Choi SH, Lim S, Yi KH, Park DJ, Jang HC, Park YJ.
    Clin Endocrinol (Oxf); 2014 May 30; 80(5):735-42. PubMed ID: 24117478
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.